Prognostic importance of c-erbB-2 expression in breast cancer

Journal of Clinical Oncology

Volumn 10, Issue 7, 1992, Pages 1049-1056

  Gusterson, B A ^a   Gelber, R D ^a   Goldhirsch, A ^a   Price, K N ^a   Save Soderborgh, J ^a   Anbazhagan, R ^a   Styles, J ^a   Rudenstam, C M ^a   Golouh, R ^a   Reed, R ^a   Martinez Tello, F ^a   Tiltman, A ^a   Torhorst, J ^a   Grigolato, P ^a   Bettelheim, R ^a   Neville, A M ^a   Burki, K ^a   Castiglione, M ^a   Collins, J ^a  

^a International Breast Cancer Study Group   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; ESTROGEN RECEPTOR; FLUOROURACIL; METHOTREXATE; PREDNISONE; PROGESTERONE RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GENETICS; CANCER GRADING; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; ONCOGENE; ONCOGENE C ERB B 2; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0026625217     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.7.1049     Document Type: Article

References (0)